SUCLG2 identified as both a determinator of CSF Abeta1-42 levels and an attenuator of cognitive decline in Alzheimer's disease

A. Ramirez; W.M. van der Flier; C. Herold; D. Ramonet; S. Heilmann; P. Lewczuk; J. Popp; A. Lacour; D. Drichel; E. Louwersheimer; M.P. Kummer; C. Cruchaga; P. Hoffmann; C.E. Teunissen; H. Holstege; J. Kornhuber; O. Peters; A.C. Naj; V. Chouraki; C. Bellenguez; A. Gerrish; R. Heun; L. Frolich; M. Hull; L. Buscemi; S. Herms; H. Kolsch; P. Scheltens; M.M. Breteler; E. Ruther; J. Wiltfang; A. Goate; F. Jessen; W. Maier; M.T. Heneka; T. Becker; M. M. Nothen

doi:https://doi.org/10.1093/hmg/ddu372

SUCLG2 identified as both a determinator of CSF Abeta1-42 levels and an attenuator of cognitive decline in Alzheimer's disease

A. Ramirez, W.M. van der Flier, C. Herold, D. Ramonet, S. Heilmann, P. Lewczuk, J. Popp, A. Lacour, D. Drichel, E. Louwersheimer, M.P. Kummer, C. Cruchaga, P. Hoffmann, C.E. Teunissen, H. Holstege, J. Kornhuber, O. Peters, A.C. Naj, V. Chouraki, C. BellenguezA. Gerrish, R. Heun, L. Frolich, M. Hull, L. Buscemi, S. Herms, H. Kolsch, P. Scheltens, M.M. Breteler, E. Ruther, J. Wiltfang, A. Goate, F. Jessen, W. Maier, M.T. Heneka, T. Becker, M. M. Nothen

Research output: Contribution to journal › Article › Academic › peer-review

35 Citations (Scopus)

Original language	English
Pages (from-to)	6644-6658
Journal	Human Molecular Genetics
Volume	23
Issue number	24
DOIs	https://doi.org/10.1093/hmg/ddu372
Publication status	Published - 2014

Access to Document

https://doi.org/10.1093/hmg/ddu372

Cite this

Ramirez, A., van der Flier, W. M., Herold, C., Ramonet, D., Heilmann, S., Lewczuk, P., Popp, J., Lacour, A., Drichel, D., Louwersheimer, E., Kummer, M. P., Cruchaga, C., Hoffmann, P., Teunissen, C. E., Holstege, H., Kornhuber, J., Peters, O., Naj, A. C., Chouraki, V., ... Nothen, M. M. (2014). SUCLG2 identified as both a determinator of CSF Abeta1-42 levels and an attenuator of cognitive decline in Alzheimer's disease. Human Molecular Genetics, 23(24), 6644-6658. https://doi.org/10.1093/hmg/ddu372

@article{c8103501a177496b9c4820bd271f8899,

title = "SUCLG2 identified as both a determinator of CSF Abeta1-42 levels and an attenuator of cognitive decline in Alzheimer's disease",

author = "A. Ramirez and {van der Flier}, W.M. and C. Herold and D. Ramonet and S. Heilmann and P. Lewczuk and J. Popp and A. Lacour and D. Drichel and E. Louwersheimer and M.P. Kummer and C. Cruchaga and P. Hoffmann and C.E. Teunissen and H. Holstege and J. Kornhuber and O. Peters and A.C. Naj and V. Chouraki and C. Bellenguez and A. Gerrish and R. Heun and L. Frolich and M. Hull and L. Buscemi and S. Herms and H. Kolsch and P. Scheltens and M.M. Breteler and E. Ruther and J. Wiltfang and A. Goate and F. Jessen and W. Maier and M.T. Heneka and T. Becker and Nothen, {M. M.}",

year = "2014",

doi = "https://doi.org/10.1093/hmg/ddu372",

language = "English",

volume = "23",

pages = "6644--6658",

journal = "Human molecular genetics",

issn = "0964-6906",

publisher = "Oxford University Press",

number = "24",

}

Ramirez, A, van der Flier, WM, Herold, C, Ramonet, D, Heilmann, S, Lewczuk, P, Popp, J, Lacour, A, Drichel, D, Louwersheimer, E, Kummer, MP, Cruchaga, C, Hoffmann, P, Teunissen, CE , Holstege, H, Kornhuber, J, Peters, O, Naj, AC, Chouraki, V, Bellenguez, C, Gerrish, A, Heun, R, Frolich, L, Hull, M, Buscemi, L, Herms, S, Kolsch, H, Scheltens, P, Breteler, MM, Ruther, E, Wiltfang, J, Goate, A, Jessen, F, Maier, W, Heneka, MT, Becker, T & Nothen, MM 2014, 'SUCLG2 identified as both a determinator of CSF Abeta1-42 levels and an attenuator of cognitive decline in Alzheimer's disease', Human Molecular Genetics, vol. 23, no. 24, pp. 6644-6658. https://doi.org/10.1093/hmg/ddu372

TY - JOUR

T1 - SUCLG2 identified as both a determinator of CSF Abeta1-42 levels and an attenuator of cognitive decline in Alzheimer's disease

AU - Ramirez, A.

AU - van der Flier, W.M.

AU - Herold, C.

AU - Ramonet, D.

AU - Heilmann, S.

AU - Lewczuk, P.

AU - Popp, J.

AU - Lacour, A.

AU - Drichel, D.

AU - Louwersheimer, E.

AU - Kummer, M.P.

AU - Cruchaga, C.

AU - Hoffmann, P.

AU - Teunissen, C.E.

AU - Holstege, H.

AU - Kornhuber, J.

AU - Peters, O.

AU - Naj, A.C.

AU - Chouraki, V.

AU - Bellenguez, C.

AU - Gerrish, A.

AU - Heun, R.

AU - Frolich, L.

AU - Hull, M.

AU - Buscemi, L.

AU - Herms, S.

AU - Kolsch, H.

AU - Scheltens, P.

AU - Breteler, M.M.

AU - Ruther, E.

AU - Wiltfang, J.

AU - Goate, A.

AU - Jessen, F.

AU - Maier, W.

AU - Heneka, M.T.

AU - Becker, T.

AU - Nothen, M. M.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.1093/hmg/ddu372

DO - https://doi.org/10.1093/hmg/ddu372

M3 - Article

C2 - 25027320

SN - 0964-6906

VL - 23

SP - 6644

EP - 6658

JO - Human molecular genetics

JF - Human molecular genetics

IS - 24

ER -